385 related articles for article (PubMed ID: 7635469)
1. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis in Jews: frequency and mutation distribution.
Kerem B; Chiba-Falek O; Kerem E
Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
[TBL] [Abstract][Full Text] [Related]
3. Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening.
Quint A; Lerer I; Sagi M; Abeliovich D
Am J Med Genet A; 2005 Jul; 136(3):246-8. PubMed ID: 15948195
[TBL] [Abstract][Full Text] [Related]
4. Difference in frequencies of the cystic fibrosis alleles, delta F508 and W1282X, between carriers and patients.
Kalman YM; Kerem E; Darvasi A; DeMarchi J; Kerem B
Eur J Hum Genet; 1994; 2(2):77-82. PubMed ID: 8044659
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of cystic fibrosis mutations in Israeli Jews.
Orgad S; Neumann S; Loewenthal R; Netanelov-Shapira I; Gazit E
Genet Test; 2001; 5(1):47-52. PubMed ID: 11336401
[TBL] [Abstract][Full Text] [Related]
6. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
Peretz H; Mulai A; Usher S; Zivelin A; Segal A; Weisman Z; Mittelman M; Lupo H; Lanir N; Brenner B; Shpilberg O; Seligsohn U
Blood; 1997 Oct; 90(7):2654-9. PubMed ID: 9326232
[TBL] [Abstract][Full Text] [Related]
7. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.
Abeliovich D; Lavon IP; Lerer I; Cohen T; Springer C; Avital A; Cutting GR
Am J Hum Genet; 1992 Nov; 51(5):951-6. PubMed ID: 1384328
[TBL] [Abstract][Full Text] [Related]
8. The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs.
Lerer I; Cohen S; Chemke M; Sanilevich A; Rivlin J; Golan A; Yahav J; Friedman A; Abeliovich D
Hum Genet; 1990 Sep; 85(4):416-7. PubMed ID: 1976595
[TBL] [Abstract][Full Text] [Related]
9. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.
Shoshani T; Augarten A; Gazit E; Bashan N; Yahav Y; Rivlin Y; Tal A; Seret H; Yaar L; Kerem E
Am J Hum Genet; 1992 Jan; 50(1):222-8. PubMed ID: 1370365
[TBL] [Abstract][Full Text] [Related]
10. Dynamic modification strategy of the Israeli carrier screening protocol: inclusion of the Oriental Jewish Group to the cystic fibrosis panel.
Reish O; Borochowitz ZU; Adir V; Shohat M; Karpati M; Shtorch A; Orr-Urtreger A; Yaron Y; Shalev S; Fares F; Gershoni-Baruch R; Falik-Zaccai TC; Chapman-Shimshoni D
Genet Med; 2009 Feb; 11(2):101-3. PubMed ID: 19265749
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis mutations delta F508 and G542X in Jewish patients.
Lerer I; Sagi M; Cutting GR; Abeliovich D
J Med Genet; 1992 Feb; 29(2):131-3. PubMed ID: 1377276
[TBL] [Abstract][Full Text] [Related]
12. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups.
Stoffman N; Magal N; Shohat T; Lotan R; Koman S; Oron A; Danon Y; Halpern GJ; Lifshitz Y; Shohat M
Eur J Hum Genet; 2000 Apr; 8(4):307-10. PubMed ID: 10854115
[TBL] [Abstract][Full Text] [Related]
13. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the hexosaminidase A gene in Ashkenazi and non-Ashkenazi Jews.
Peleg L; Karpati M; Gazit E; Raas-Rothschild A; Goldman B
Biochem Med Metab Biol; 1994 Jun; 52(1):22-6. PubMed ID: 7917464
[TBL] [Abstract][Full Text] [Related]
15. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
16. Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations.
Nakai K; Habano W; Nakai K; Fukushima N; Suwabe A; Moriya S; Osano K; Gurwitz D
Life Sci; 2005 Nov; 78(1):107-11. PubMed ID: 16111713
[TBL] [Abstract][Full Text] [Related]
17. Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel.
Daniels M; Shohat T; Brenner-Ullman A; Shohat M
Am J Med Genet; 1995 Jan; 55(3):311-4. PubMed ID: 7726228
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.
Tamary H; Bar-Yam R; Shalmon L; Rachavi G; Krostichevsky M; Elhasid R; Barak Y; Kapelushnik J; Yaniv I; Auerbach AD; Zaizov R
Br J Haematol; 2000 Oct; 111(1):338-43. PubMed ID: 11091222
[TBL] [Abstract][Full Text] [Related]
19. Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.
Sereth H; Shoshani T; Bashan N; Kerem BS
Hum Genet; 1993 Oct; 92(3):289-95. PubMed ID: 7691712
[TBL] [Abstract][Full Text] [Related]
20. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
